Metformin for treatment of clozapine-induced weight gain in adult patients with schizophrenia: a meta-analysis

BACKGROUND: Long-term use of clozapine for individuals with schizophrenia carries a high risk for developing metabolic abnormalities, especially clozapine-induced weight gain. Previous studies suggest that metformin can decrease clozapine-induced weight gain, but the sample sizes of most of these st...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, Zhengrong, ZHENG, Wei, GAO, Shuai, QIN, Zhisong, LI, Guannan, NING, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Municipal Bureau of Publishing 2015
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858504/
https://www.ncbi.nlm.nih.gov/pubmed/27199524
http://dx.doi.org/10.11919/j.issn.1002-0829.215071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858504/
https://www.ncbi.nlm.nih.gov/pubmed/27199524
http://dx.doi.org/10.11919/j.issn.1002-0829.215071

Ejemplares similares